Authors:
STOROGENKO M
PECHAMSELLEM MA
KERDINE S
ROUSSELET F
PALLARDY M
Citation: M. Storogenko et al., CYCLOSPORINE-A INHIBITS HUMAN ENDOTHELIAL-CELLS PROLIFERATION THROUGHINTERLEUKIN-6-DEPENDENT MECHANISMS, Life sciences, 60(17), 1997, pp. 1487-1496
Citation: A. Biola et M. Pallardy, INTERLEUKIN-2 INHIBITS GLUCOCORTICOID RECEPTOR TRANSCRIPTIONAL ACTIVITY - CONSEQUENCES FOR APOPTOSIS, British Journal of Pharmacology, 122, 1997, pp. 426-426
Authors:
RIBRAG V
TOUITOU R
BOSQ J
KOSCIELNY S
OUABDESSELAM R
NASR F
CORTI C
BRAULT P
CARDE P
HAYAT M
JOAB I
PALLARDY M
Citation: V. Ribrag et al., HIGH SERUM INTERLEUKIN-2 RECEPTOR AND INTERLEUKIN-6 LEVELS ARE ASSOCIATED WITH A POOR FREEDOM FROM PROGRESSION IN ADULT NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 3945-3945
Authors:
KERDINE S
LEBREC H
BERTOGLIO J
PALLARDY M
Citation: S. Kerdine et al., INTERLEUKIN-4 PLAYS A DOMINANT ROLE IN TH1- OR TH2-LIKE RESPONSES DURING THE PRIMARY IMMUNE-RESPONSE TO THE HAPTEN PENICILLIN, Molecular immunology, 33(1), 1996, pp. 71-77
Citation: P. Saas et al., EFFECTS OF METHYL SUBSTITUTIONS ON BENZ[A]ANTHRACENE DERIVATIVES-INDUCED IMMUNOSUPPRESSION, Journal of toxicology and environmental health, 49(4), 1996, pp. 371-387
Authors:
KERDINE S
PALLARDY M
LAMANETRE S
BERTOGLIO J
LEBREC H
Citation: S. Kerdine et al., INTERLEUKIN-10 AND INTERLEUKIN-4 HAVE SIMILAR EFFECTS ON HAPTEN-SPECIFIC PRIMARY ANTIBODY-RESPONSES TO PENICILLIN IN-VIVO, European Journal of Immunology, 26(12), 1996, pp. 2890-2894
Authors:
ROGER R
BREARD J
COMISSO M
BOHUON C
PALLARDY M
BERTOGLIO J
Citation: R. Roger et al., CD28-MEDIATED CYTOTOXICITY OF YT NATURAL-KILLER-CELLS ON B7-POSITIVE TARGETS INDUCES RAPID NECROTIC DEATH INDEPENDENT OF GRANULE EXOCYTOSIS, Cellular immunology, 168(1), 1996, pp. 24-32
Authors:
ROGER R
ISSAAD C
PALLARDY M
LEGLISE MC
TURHAN AG
BERTOGLIO J
BREARD J
Citation: R. Roger et al., BCR-ABL DOES NOT PREVENT APOPTOTIC DEATH INDUCED BY HUMAN NATURAL-KILLER OR LYMPHOKINE-ACTIVATED KILLER-CELLS, Blood, 87(3), 1996, pp. 1113-1122
Authors:
PERRINWOLFF M
MISHAL Z
BERTOGLIO J
PALLARDY M
Citation: M. Perrinwolff et al., POSITION-16 OF THE STEROID NUCLEUS MODULATES GLUCOCORTICOID-INDUCED APOPTOSIS AT THE TRANSCRIPTIONAL LEVEL IN MURINE T-LYMPHOCYTES, Biochemical pharmacology, 52(9), 1996, pp. 1469-1476
Citation: M. Pallardy et al., ANTIBIOTICS AND ALLERGIES - LYMPHOCYTE-AC TIVATION AND EQUILIBRIUM BETWEEN TH1 AND TH2 LYMPHOCYTES, Archives de pediatrie, 2, 1995, pp. 103-104
Authors:
LEBREC H
ROGER R
BLOT C
BURLESON GR
BOHUON C
PALLARDY M
Citation: H. Lebrec et al., IMMUNOTOXICOLOGICAL INVESTIGATION USING PHARMACEUTICAL DRUGS - IN-VITRO EVALUATION OF IMMUNE EFFECTS USING RODENT OR HUMAN IMMUNE CELLS, Toxicology, 96(2), 1995, pp. 147-156
Authors:
ESCUDIER B
FARACE F
THEODORE C
ANGEVIN E
COURT B
COUANET D
DIETRICH PY
CULINE S
PALLARDY M
HERCEND T
DROZ JP
Citation: B. Escudier et al., A NEW SCHEDULE OF INTERLEUKIN-2 FOR METASTATIC RENAL-CELL CARCINOMA -THE INSTITUT GUSTAVE-ROUSSY STUDY, Bulletin du cancer, 82(4), 1995, pp. 296-302
Authors:
PAILLER C
SAAS P
BOURHIS JH
PICO JL
PALLARDY M
Citation: C. Pailler et al., A NEW NON MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED CYTOTOXICITY (MHC) FOLLOWING PERIPHERAL HEMATOPOIETIC STEM-CELL AUTOGRAFTS, Blood, 86(10), 1995, pp. 1272-1272
Authors:
PERRINWOLFF M
BERTOGLIO J
BRESSAC B
BOHUON C
PALLARDY M
Citation: M. Perrinwolff et al., STRUCTURE-ACTIVITY-RELATIONSHIPS IN GLUCOCORTICOID-INDUCED APOPTOSIS IN T-LYMPHOCYTES, Biochemical pharmacology, 50(1), 1995, pp. 103-110
Authors:
BLOT C
LEBREC H
ROGER R
BOHUON R
PALLARDY M
Citation: C. Blot et al., IMMUNE PARAMETERS ARE AFFECTED DIFFERENTLY AFTER CYCLOSPORINE-A EXPOSURE IN FISCHER-344 RATS AND B6C3F1 MICE - IMPLICATIONS FOR IMMUNOTOXICOLOGY, Toxicology, 94(1-3), 1994, pp. 231-245
Authors:
LEBREC H
BLOT C
PEQUET S
ROGER R
BOHUON C
PALLARDY M
Citation: H. Lebrec et al., IMMUNOTOXICOLOGICAL INVESTIGATION USING PHARMACEUTICAL DRUGS - IN-VIVO EVALUATION OF IMMUNE EFFECTS, Fundamental and applied toxicology, 23(2), 1994, pp. 159-168
Authors:
FARACE F
PALLARDY M
ANGEVIN E
HERCEND T
ESCUDIER B
TRIEBEL F
Citation: F. Farace et al., METASTATIC RENAL-CELL CARCINOMA PATIENTS TREATED WITH INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERFERON-GAMMA - IMMUNOLOGICAL MONITORING, International journal of cancer, 57(6), 1994, pp. 814-821